Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Celanese (CE)

Celanese Q2 adjusted EPS rises to $2.45; Q3 adjusted EPS guided to $1.35 to $1.75

Mixed Impact 4 of 5 earnings Written later

Celanese reported second quarter 2026 net sales of $2.8 billion, up 18 percent sequentially, and adjusted earnings per share of $2.45, compared with $1.43 a year earlier. Its U.S. GAAP diluted EPS from continuing operations fell to $1.15 from $1.89 a year earlier, and management expects third quarter adjusted EPS of about $1.35 to $1.75, moderating from the second quarter.

Key points

  • Net sales $2.752 billion in Q2 2026 vs. $2.337 billion in Q1 2026 and $2.532 billion in Q2 2025
  • Adjusted EPS $2.45 vs. $0.85 in Q1 2026 and $1.43 in Q2 2025; management called it the highest in nearly three years
  • Q3 2026 adjusted EPS expected at approximately $1.35 to $1.75; full-year 2026 adjusted EPS of approximately $6.00 and free cash flow of $700 to $800 million reaffirmed
  • Q2 free cash flow was $140 million, down from $311 million in Q2 2025

The filing

CompanyCelanese (CE)
Form8-K, current report
Filed with the SECAug 4, 2026, 4:20 PM ET
Accession number0001306830-26-000113

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 04, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.